Umberto Capitanio

Dr. Umberto Capitanio

1. Department of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy
+2

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in European Urology
Verified
Journal Article
Closed access
UCUmberto Capitanio
Umberto Capitanio
KBKarim Bensalah
Karim Bensalah
ABAxel Bex
Axel Bex
SBStephen A. Boorjian
Stephen A. Boorjian
FBFreddie Bray
Freddie Bray
PRPaul Russo
Paul Russo

1 February 2016 in The Lancet
Verified
Journal Article
Closed access
UCUmberto Capitanio
Umberto Capitanio
FMFrancesco Montorsi
Francesco Montorsi

1 March 2012 in European Urology
Verified
Journal Article
Closed access
ABAlberto Briganti
Alberto Briganti
ALAlessandro Larcher
Alessandro Larcher
FAFiras Abdollah
Firas Abdollah
UCUmberto Capitanio
Umberto Capitanio
AGAndrea Gallina
Andrea Gallina
FMFrancesco Montorsi
Francesco Montorsi

4 February 2009 in Cancer
Verified
Journal Article
Open access
PDF file
LZLaurent Zini
Laurent Zini
PPPaul Perrotte
Paul Perrotte
UCUmberto Capitanio
Umberto Capitanio
CJClaudio Jeldres
Claudio Jeldres
SSShahrokh F. Shariat
Shahrokh F. Shariat
PKPierre I. Karakiewicz
Pierre I. Karakiewicz
BACKGROUND: Relative to radical nephrectomy (RN), partial nephrectomy (PN) performed for renal cell carcinoma (RCC) may protect from non‐cancer‐related deaths. The authors tested this hypothesis in a cohort of PN and RN patients.METHODS: The Surveillance, Epidemiology, and End Results‐9 database allowed identification of 2198 PN (22.4%) and 7611 RN (77.6%) patients treated for T1aN0M0 RCC between 1988 and 2004. Analyses matched for age, year of surgery, tumor size, and Fuhrman grade addressed the effect of nephrectomy type (RN vs PN) on overall mortality (Cox regression models) and on non‐cancer‐related mortality (competing‐risks regression models).RESULTS: Relative to PN, RN was associated with 1.23‐fold (P = .001) increased overall mortality rate, which translated into a 4.9% and 3.1% absolute increase in mortality at 5 and 10 years after surgery, respectively. Similarly, non‐cancer‐related death rate was significantly higher after RN in competing‐risks regression models (P < .001), which translated into a 4.6% and 4.5% absolute increase in non‐cancer‐related mortality at 5 and 10 years after surgery, respectively.CONCLUSIONS: Relative to PN, RN predisposes to an increase in overall mortality and non‐cancer‐related death rate in patients with T1a RCC. In consequence, PN should be attempted whenever technically feasible. Selective referrals should be considered if PN expertise is unavailable Cancer 2009. © 2009 American Cancer Society.

1 April 2015 in European Urology
Verified
Journal Article
Closed access
UCUmberto Capitanio
Umberto Capitanio
CTCarlo Terrone
Carlo Terrone
AAAlessandro Antonelli
Alessandro Antonelli
AMAndrea Minervini
Andrea Minervini
AVAlessandro Volpe
Alessandro Volpe
RBRoberto Bertini
Roberto Bertini

1 February 2015 in European Urology
Verified
Journal Article
Closed access
FAFiras Abdollah
Firas Abdollah
GGGiorgio Gandaglia
Giorgio Gandaglia
NSNazareno Suardi
Nazareno Suardi
UCUmberto Capitanio
Umberto Capitanio
ASAndrea Salonia
Andrea Salonia
ABAlberto Briganti
Alberto Briganti